Risks of Endometrial Carcinogenesis and Assisted Reproductive Technologies: A Systematic Review and Meta-Analysis
Keywords:
Social integration, responsibilities, relationships and mentorship, Metastasis., resistance, Genomics, sequencing, prosigna, transduction., In Vitro Fertilization, Meta-Analysis, uterine cancer, infertility, ovulation inductionAbstract
Purpose of study: to study the possible relationship between in vitro fertilization, the use of ovulation stimulation drugs and the risk of developing uterine cancer in women with infertility.
Material and methods: literature search for a systematic review was carried out in the bibliographic databases Medline, ClinicalKey, Google Scholar, Embase, The Cochrane Library, eLIBRARY for the period 1999-2022. Publications were searched using keywords defined according to the PICO principle (P = population or patients, I = intervention, C = comparison and O = outcomes): female, women, infertility, infertility treatment, in vitro fertilization, IVF, assisted reproductive technologies, ART, ovarian stimulation, ovarian hyperstimulation, clomiphene citrate, hCG, hMG, tamoxifen, uterine, endometrial, cancer, carcinoma neoplasm, uterine neoplasms. The following SQL operators were used during the search: AND, OR.
Results: As a result of the search, 37 representative publications were found, during the selection process 8 studies were selected for meta-analysis.
Conclusion: A systematic review and meta-analysis has demonstrated the ambiguity of the design and results of studies on the possible relationship of uterine cancer and methods of assisted reproductive technologies published to date. The problem is very relevant due to the high incidence of infertility and the increase in the incidence of cancer of the female reproductive organs. The conducted studies confirm the impossibility to evaluate in isolation the carcinogenic effect of ovulation inducers or in vitro fertilization methods without adjusting for the infertility factor, as well as risk factors for uterine cancer. There remains a high need for more research as well as for the safety profile of infertility treatments in relation to long-term cancer risks.
References
Fillipov (2019) Does the use of fertility medications increase the risk of cancer? A review study. 10, 313. https://doi.org/10.3389/fendo.2019.00313
Fillipov (2002) Prichiny i faktory razvitiya besplodiya sredi naseleniya Sibiri. ((2)), 47–49.
Tatiana Ustinova, Artymuk, Vlasova, Pyzhov (2010) Infertility in couples of Kemerovo region. 1(40), 37–39.
Zurab Darzhaev, Atalyan, Rinchindorzhiyeva, Suturina (2017) Prevalence of female infertility among urban and rural population in Buryat republic. 2(4), 14–21. https://doi.org/10.23946/2500-0764-2017-2-4-14-21
Natalia Frolova, Belokrinitskaya, Anokhova (2014) Prevalence and characteristics of infertility in young women of reproductive age living in Zabaykalsky district. 4(98), 54–58.
Alexey Feoktistov (2006) Matochnyy faktor v klinike zhenskogo besplodiya.
Linda Kroener, Dumesic, Al-Safi (2017) Use of fertility medications and cancer risk: a review and update. 29(4), 195–201. https://doi.org/10.1097/GCO.000000000000370
Laura Del Pup, Peccatori, Levi-Setti (2018) Risk of cancer after assisted reproduction: a review of the available evidences and guidance to fertility counselors. 22(22), 8042–8059. https://doi.org/10.26355/eurrev_201811_16434
Louis Louis, Saso, Ghaem-Maghami (2013) The relationship between infertility treatment and cancer including gynaecological cancers. 15(3), 177–183. https://doi.org/10.1111/tog.12040
Vladimir Korsak, Smirnova, Shurygina (2017) Registr centrov VRT v Rossii. Otchet za 2015 g.. 23(5), 8–22. https://doi.org/10.17116/repro20172358-22
Siri Berntsen, Söderström-Anttila, Wennerholm (2019) The health of children conceived by ART: “the chicken or the egg?”. 25(2), 137–158. https://doi.org/10.1093/humupd/dmz001
Marianne Reigstad, Larsen, Myklebust (2015) Cancer risk among parous women following assisted reproductive technology. 30(8), 1952–1963. https://doi.org/10.1093/humrep/dev124
Christina Siristatidis, Sergentanis, Kanavidis (2013) Controlled ovarian hyperstimulation for IVF: impact on ovarian, endometrial and cervical cancer – a systematic review and meta-analysis. 19(2), 105–123. https://doi.org/10.1093/humupd/dms051
Aksel YeM (2009) Statistics of gynecological malignancies. ((1–2)), 76–80. https://doi.org/10.17650/1994-4098-2009-0-1-2-76-80
AD Kaprin, VV Starinskiy, GV Petrova (2018) Zlokachestvennye novoobrazovaniya v Rossii v 2017 godu (zabolevaemost’ i smertnost'). https://glavonco.ru/upload/pages/cancer-register/statistika_zabol_2017.pdf
VA Katzke, R Kaaks, T Kühn (2015) Lifestyle and cancer risk. 21(2). https://doi.org/10.1097/PPO.0000000000000101
Human Fertilisation and Embryology Authority (HFEA) (2011) United Kingdom IVF figures. https://www.hfea.gov.uk/
LA Brinton, B Trabert, V Shalev (2013) In vitro fertilization and risk of breast and gynecologic cancers. 99(5), 1189–1196. https://doi.org/10.1016/j.fertnstert.2012.12.029
P Kristiansson, O Björ, H Wramsby (2007) Tumour incidence in Swedish women who gave birth following IVF treatment. 22(2), 421–426. https://doi.org/10.1093/humrep/del411
CL Williams, ME Jones, AJ Swerdlow (2018) Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology. 362, k2644. https://doi.org/10.1136/bmj.k2644
A Venn, L Watson, F Bruinsma (1999) Risk of cancer after use of fertility drugs with in-vitro fertilization. 354, 1586–1590. https://doi.org/10.1016/S0140-6736(99)05203-4
Dor J, Lerner-Geva L, Rabinovici J (2002) Cancer incidence in a cohort of infertile women who underwent in vitro fertilization. 77, 324–327. https://doi.org/10.1016/S0015-0282(01)02986-7
B Luke, MB Brown, LG Spector (2015) Cancer in women after assisted reproductive technology. 104, 1218–1226. https://doi.org/10.1016/j.Fertnstert.201507.1135
A-N Yli-Kuha, M Gissler, R Klemetti (2012) Cancer morbidity in a cohort of 9175 Finnish women treated for infertility. 27, 1149–1155. https://doi.org/10.1093/humrep/des031
R Kessous, E Davidson, M Meirovitz (2016) The risk of female malignancies after fertility treatments: a cohort study with 25-year follow-up. 142(1), 287–293. https://doi.org/10.1007/s00432-015-2035-x
Silva Idos, P A Wark, V A McCormack, et al. (2009) Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort. 100(11), 1824–1831. https://doi.org/10.1038/sj.bjc.6605086
A Skalkidou, T N Sergentanis, S P Gialamas, et al. (2017) Risk of endometrial cancer in women treated with ovary-stimulating drugs for subfertility. (3), CD010931. https://doi.org/10.1002/14651858.CD010931.pub2
M D Althuis, K S Moghissi, C L Westhoff, et al. (2005) Uterine cancer after use of clomiphene citrate to induce ovulation. 161(7), 607–615. https://doi.org/10.1093/aje/kwi084
I Cetin, V Cozzi, P Antonazzo (2008) Infertility as a cancer risk factor – a review. 29(Suppl B), 169–177. https://doi.org/10.1016/j.placenta.2008.08.007
H P Yang, L S Cook, E Weiderpass, et al. (2015) Infertility and incident endometrial cancer risk: a pooled analysis from the epidemiology of endometrial cancer consortium (E2C2). 112(5), 925–933. https://doi.org/10.1038/bjc.2015.24
Practice Committee of the American Society for Reproductive Medicine (2016) Fertility drugs and cancer: A guideline. 106(7), 1617–1626. https://doi.org/10.1016/j.fertnstert.2016.08.035
L Lerner-Geva, J Rabinovici, L Olmer, et al. (2012) Are infertility treatments a potential risk factor for cancer development? Perspective of 30 years of follow-up. 28(10), 809–814. https://doi.org/10.3109/09513590.2012.671391
S Saso, L S Louis, F Doctor, et al. (2015) Does fertility treatment increase the risk of uterine cancer? A meta-analysis. 195, 52–60. https://doi.org/10.1016/j.ejogrb.2015.09.002
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Authors and Global Journals Private Limited
This work is licensed under a Creative Commons Attribution 4.0 International License.
